Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)‐reactivating agents enhance efficacy of 5‐fluorouracil on human colon cancer cells

Motoki Watanabe(Kyoto Prefectural University of Medicine), Toshiyuki Sakai(Kyoto Prefectural University of Medicine)
Cancer Science
February 26, 2013
Cited by 49


Related Papers